These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34504961)

  • 1. Isolated progression of miliary brain metastasis in a patient with stable lung adenocarcinoma successfully treated with whole-brain radiotherapy: A case report.
    Hiya S; Fujiwara S; Nakagawa A; Sato Y; Omura Y; Hara S; Kohara N; Kawamoto M
    eNeurologicalSci; 2021 Dec; 25():100366. PubMed ID: 34504961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miliary brain metastasis presenting with calcification in a patient with lung cancer: a case report.
    Inomata M; Hayashi R; Kambara K; Okazawa S; Imanishi S; Ichikawa T; Suzuki K; Yamada T; Miwa T; Kashii T; Matsui S; Tobe K; Sasahara M
    J Med Case Rep; 2012 Sep; 6():279. PubMed ID: 22947115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miliary brain metastases from lung adenocarcinoma as non-enhancing lesions on MRI: a case report and literature review.
    Huang Z; Xie D; Yang P; Song E; Zhang J; Chen J; Qin F
    Transl Cancer Res; 2021 Feb; 10(2):1162-1168. PubMed ID: 35116443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly progressive miliary brain metastasis of lung cancer after EGFR tyrosine kinase inhibitor discontinuation: An autopsy report.
    Kurihara M; Koda H; Aono H; Sugimoto I; Sakurai Y; Sano T; Saito Y; Murayama S; Mori M
    Neuropathology; 2019 Apr; 39(2):147-155. PubMed ID: 30868686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic Adenocarcinoma of the Lung Mimicking Miliary Tuberculosis and Pott's Disease.
    Khan D; Saddique MU; Paul T; Murshed K; Zahid M
    Cureus; 2021 Jan; 13(1):e12869. PubMed ID: 33633898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial remission with brigatinib rechallenge as fifth-line ALK inhibition therapy in a lung cancer patient.
    Hochmair M; Weinlinger C; Prosch H
    Anticancer Drugs; 2019 Nov; 30(10):1058-1060. PubMed ID: 31033499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Miliary cerebral carcinomatosis secondary to EGFR mutation-positive lung adenocarcinoma].
    Dumoulin J; Rozensztajn N; Paradis M; Sellier J; Abel A; Giraud P; Labrune S; Chinet T
    Rev Mal Respir; 2016 Jan; 33(1):67-71. PubMed ID: 25794997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miliary brain metastases from occult lung adenocarcinoma: Radiologic and histopathologic confirmation.
    Kahveci R; Gürer B; Kaygusuz G; Sekerci Z
    J Neurosci Rural Pract; 2012 Sep; 3(3):386-9. PubMed ID: 23189010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Miliary Brain Metastases Molecularly Diagnosed as Silent Lung Adenocarcinoma Origin].
    Nagai T; Takeuchi H; Kamata K; Kawabe T; Takahashi Y; Hashimoto N
    No Shinkei Geka; 2020 Aug; 48(8):701-706. PubMed ID: 32830134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcific Miliary Brain Metastasis in Adenocarcinoma Lung Treated with Gefitinib.
    Divya KP; Cherian A; Prabhakaran PK; Thomas B; Shetty K
    Neurol India; 2022; 70(3):1197-1199. PubMed ID: 35864664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenocarcinoma of the Lung Presenting with Intrapulmonary Miliary Metastasis.
    Pillai S; Khan A; Khan S
    Cureus; 2019 Aug; 11(8):e5430. PubMed ID: 31632879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central Nervous System Miliary Brain Metastasis Secondary to Breast Cancer.
    Santos Vázquez G; Garcia Cázarez R; Moreno Pizarro E; Serrano Padilla AE; Plascencia Salcedo JC
    Cureus; 2020 Aug; 12(8):e9649. PubMed ID: 32923249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miliary lung metastases from ROS1-rearranged lung adenocarcinoma: A case report.
    Otoshi R; Sekine A; Okudela K; Katano T; Asaoka M; Ikeda S; Baba T; Komatsu S; Hagiwara E; Takashi O
    Mol Clin Oncol; 2020 Jul; 13(1):80-82. PubMed ID: 32454978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the Lung Mimicking Miliary Tuberculosis.
    Khan D; Danjuma M; Saddique MU; Murshed KAH; Yassin MA
    Case Rep Oncol; 2020; 13(1):139-144. PubMed ID: 32231535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brigatinib and Alectinib for ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer With or Without Central Nervous System Metastasis: A Systematic Review and Network Meta-Analysis.
    Ando K; Akimoto K; Sato H; Manabe R; Kishino Y; Homma T; Kusumoto S; Yamaoka T; Tanaka A; Ohmori T; Sagara H
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.
    Camidge DR; Kim HR; Ahn MJ; Yang JC; Han JY; Lee JS; Hochmair MJ; Li JY; Chang GC; Lee KH; Gridelli C; Delmonte A; Garcia Campelo R; Kim DW; Bearz A; Griesinger F; Morabito A; Felip E; Califano R; Ghosh S; Spira A; Gettinger SN; Tiseo M; Gupta N; Haney J; Kerstein D; Popat S
    N Engl J Med; 2018 Nov; 379(21):2027-2039. PubMed ID: 30280657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer.
    Popat S; Brustugun OT; Cadranel J; Felip E; Garassino MC; Griesinger F; Helland Å; Hochmair M; Pérol M; Bent-Ennakhil N; Kruhl C; Novello S
    Lung Cancer; 2021 Jul; 157():9-16. PubMed ID: 34051652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with brigatinib in a patient with ALK-rearranged lung adenocarcinoma who developed crizotinib-induced interstitial lung disease.
    Doménech M; Jové M; Aso S; Marín M; Nadal E
    Lung Cancer; 2018 May; 119():99-102. PubMed ID: 29656760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial.
    Gettinger SN; Bazhenova LA; Langer CJ; Salgia R; Gold KA; Rosell R; Shaw AT; Weiss GJ; Tugnait M; Narasimhan NI; Dorer DJ; Kerstein D; Rivera VM; Clackson T; Haluska FG; Camidge DR
    Lancet Oncol; 2016 Dec; 17(12):1683-1696. PubMed ID: 27836716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ALK-positive lung adenocarcinoma with gastric and skin metastasis: a case report and literature review.
    Duan X; Zhao X; Wang S
    Ann Palliat Med; 2021 May; 10(5):5797-5807. PubMed ID: 32819126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.